An article about our suggested Code of Good Practice for Manufacturers written by Chinaniso Majoni, Senior Nomenclature Developer & Quality Lead at the GMDN Agency
A feature on the requirements of a medical device nomenclature written by Edward Glenn, Senior Nomenclature Developer & Business Development Lead at the GMDN Agency
The GMDN Agency CEO, Deniz Bruce, and Senior Clinical Lead, Dr Barry Daniels, attended the IMDRF (International Medical Device Regulators Forum) Meeting
MHRA and ANVISA representatives have joined the Authorities Strategic Advisory Group (ASAG) committee, which represents medical device regulators that use the GMDN.